NOS3 and diabetes mellitus: In a RCT assessing the effect of liraglutide and exenatide in patients with and without diabetes, injection of both liraglutide and exenatide increased local skin perfusion when compared to saline, in a mechanism thought to be mediated by endothelial nitric oxide synthase (eNOS) [56].